Results 101 to 110 of about 5,969 (169)

Ambroxol for the treatment of fibromyalgia: science or fiction?

Journal of Pain Research, 2017
Kai-Uwe Kern, Myriam Schwickert Institute of Pain Medicine/Pain Practice, Wiesbaden, Germany Abstract: Fibromyalgia appears to present in subgroups with regard to biological pain induction, with primarily inflammatory, neuropathic/neurodegenerative ...
Kern KU, Schwickert M
doaj  

Clinical efficacy of ambroxol combined with cefoperazone sodium and sulbactam sodium in the treatment of senile severe pneumonia

Guoji laonian yixue zazhi
[Objective] To investigate the clinical efficacy of ambroxol combined with cefoperazone sodium and sulbactam sodium in the treatment of elderly patients with severe pneumonia.
Lu Qiuying, Gao Yanfen, Shan Yan, Xu Yaping   +3 more
doaj   +1 more source

ANALYSIS OF QUALITY INDICATORS AND PARAMETRS OF SYRUP AMBROXOL PRODUCTION USING STATISTICAL METHODS

Разработка и регистрация лекарственных средств, 2019
The quality review procedure, which is an essential improvement of the quality system by manufacturers, was used for monitoring the stability of the production process and quality of Ambroxol syrup.
S. N. Egorova, M. R. Mtsariashvili, V. A. Sevodin, S. Yu. Garmonov   +3 more
doaj  

Marked improvement in autoimmune pulmonary alveolar proteinosis with severe hypoxemia in a patient treated with ambroxol: a case report [PDF]

, 2015
Harukazu Yoshimatsu, Hirofumi Matsuoka, Koji Tamai, Nao Oda, Nobuhiko Okada, Yujiro Suzuki, Yusuke Matsumoto   +6 more
core   +1 more source

Development and Characterization of Spray-Dried Combined Levofloxacin–Ambroxol Dry Powder Inhaler Formulation

Pharmaceutics
Background: This study explores the development and characterization of spray-dried composite microparticles consisting of levofloxacin (LVX, a broad-spectrum antibiotic), and ambroxol (AMB, a mucolytic agent that has antibacterial and antibiofilm ...
Ruwani K. Suraweera, Kirsten M. Spann, Emad L. Izake, Timothy J. Wells, Xiaodong Wang, Nazrul Islam   +5 more
doaj   +1 more source

Inhibition of PAF-induced aggregation of human PMNs and platelets by adenosine: in vitro investigations using a newly developed blood filtration system [PDF]

, 1992
Arbogast, Helmut, Dammer, U., Dendorfer, A., Meier-Ewert, H., Nees, S., Schönharting, M., Stiegler, H., Strohmenger, R.   +7 more
core   +1 more source

Phytotherapeutic and naturopathic adjuvant therapies in otorhinolaryngology [PDF]

, 2011
Raphael Richard Ciuman
core   +1 more source

Protocol of ASPro-PD: a phase 3 trial of ambroxol to slow progression in genetically stratified Parkinson's disease. [PDF]

J Neurol
Toffoli M, Menozzi E, Cullen M, Chowdhury K, Ahmed S, Freemantle N, Duffen J, Wyse RK, Stott SRW, Matthews H, Dexter D, Ikeji F, Moss J, Watts P, Foltynie T, Kieburtz K, Rascol O, Poewe W, Schapira AHV.   +18 more
europepmc   +1 more source

Modest improvement of metabolic and behavioral deficits with long-term ambroxol treatment in a Pink1^-/-SNCA^A53T double mutant mouse model of Parkinson's disease. [PDF]

Acta Pharmacol Sin
Franck L, Valek L, Hahnefeld L, Trautmann S, Angioni C, Weyer MP, Thomas D, Gurke R, Wittig I, Geisslinger G, Tegeder I.   +10 more
europepmc   +1 more source

The use of genistein and ambroxol may be an effective approach in correcting cellular dysfunctions of mucopolysaccharidosis-plus syndrome. [PDF]

Mamm Genome
Cyske Z, Rintz E, Gaffke L, Pierzynowska K, Węgrzyn G.   +4 more
europepmc   +1 more source